Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinichi Takatsuki

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Pediatrics International : Official Journal of the Japan Pediatric Society|September 30, 2017
Low risk of treatment resistance in Down syndrome with Kawasaki diseaseShinichi Takatsuki, Shohei Ogata, Masahiro Ishii, et al.
Journal of Clinical Medicine|February 13, 2026
Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral ArteriesKeiichi Hirono, Keiko Uchida, Taku Ishii, et al.
Cardiovascular Research|November 30, 2019
Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki diseaseYasutaka Nakashima, Yasunari Sakai, Yumi Mizuno, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 15, 2020
Pregnancy and Delivery in Patients With Repaired Congenital Heart Disease　- A Retrospective Japanese Multicenter StudyShinichi Takatsuki, Yoshiyuki Furutani, Kei Inai, et al.
Lancet (London, England)|March 13, 2012
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trialTohru Kobayashi, Tsutomu Saji, Tetsuya Otani, et al.
International Journal of Cardiology|January 10, 2012
Clinical features of adult patients with Eisenmenger's syndrome in Japan and KoreaHisanori Sakazaki, Koichiro Niwa, Makoto Nakazawa, et al.
International Journal of Cardiology|July 16, 2013
Coronary artery outcomes among children with Kawasaki disease in the United States and JapanShohei Ogata, Adriana H Tremoulet, Yuichiro Sato, et al.
International Journal of Cardiology. Congenital Heart Disease|May 27, 2026
Registry-based estimation of cardiac event-free survival in congenital heart disease complicated by pulmonary hypertension: A nationwide registry study from JapanTaku Ishii, Tatsuhiko Anzai, Keiko Uchida, et al.
Lancet (London, England)|March 12, 2019
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trialHiromichi Hamada, Hiroyuki Suzuki, Yoshihiro Onouchi, et al.
Human Molecular Genetics|April 29, 2010
Common variants in CASP3 confer susceptibility to Kawasaki diseaseYoshihiro Onouchi, Kouichi Ozaki, Jane C Buns, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Pediatrics International : Official Journal of the Japan Pediatric Society|September 30, 2017
Low risk of treatment resistance in Down syndrome with Kawasaki diseaseShinichi Takatsuki, Shohei Ogata, Masahiro Ishii, et al.
Journal of Clinical Medicine|February 13, 2026
Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral ArteriesKeiichi Hirono, Keiko Uchida, Taku Ishii, et al.
Cardiovascular Research|November 30, 2019
Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki diseaseYasutaka Nakashima, Yasunari Sakai, Yumi Mizuno, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 15, 2020
Pregnancy and Delivery in Patients With Repaired Congenital Heart Disease　- A Retrospective Japanese Multicenter StudyShinichi Takatsuki, Yoshiyuki Furutani, Kei Inai, et al.
Lancet (London, England)|March 13, 2012
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trialTohru Kobayashi, Tsutomu Saji, Tetsuya Otani, et al.
International Journal of Cardiology|January 10, 2012
Clinical features of adult patients with Eisenmenger's syndrome in Japan and KoreaHisanori Sakazaki, Koichiro Niwa, Makoto Nakazawa, et al.
International Journal of Cardiology|July 16, 2013
Coronary artery outcomes among children with Kawasaki disease in the United States and JapanShohei Ogata, Adriana H Tremoulet, Yuichiro Sato, et al.
International Journal of Cardiology. Congenital Heart Disease|May 27, 2026
Registry-based estimation of cardiac event-free survival in congenital heart disease complicated by pulmonary hypertension: A nationwide registry study from JapanTaku Ishii, Tatsuhiko Anzai, Keiko Uchida, et al.
Lancet (London, England)|March 12, 2019
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trialHiromichi Hamada, Hiroyuki Suzuki, Yoshihiro Onouchi, et al.
Human Molecular Genetics|April 29, 2010
Common variants in CASP3 confer susceptibility to Kawasaki diseaseYoshihiro Onouchi, Kouichi Ozaki, Jane C Buns, et al.
Pageof 5